Jeff Garro
Stock Analyst at Stephens & Co.
(1.03)
# 3,586
Out of 4,735 analysts
48
Total ratings
29.73%
Success rate
-12.64%
Average return
Main Sectors:
Stocks Rated by Jeff Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Reiterates: Overweight | $26 | $22.24 | +16.91% | 3 | Jan 7, 2025 | |
| DH Definitive Healthcare | Initiates: Equal-Weight | $5 | $3.94 | +26.90% | 1 | Dec 20, 2024 | |
| DOCS Doximity | Initiates: Equal-Weight | $55 | $53.72 | +2.38% | 1 | Dec 20, 2024 | |
| VEEV Veeva Systems | Initiates: Overweight | n/a | $216.59 | - | 1 | Dec 20, 2024 | |
| OPRX OptimizeRx | Initiates: Equal-Weight | $5.5 | $4.81 | +14.46% | 3 | Dec 20, 2024 | |
| IQV IQVIA Holdings | Initiates: Overweight | $250 | $197.36 | +26.67% | 2 | Dec 20, 2024 | |
| HNRG Hallador Energy Company | Initiates: Buy | $17 | $12.68 | +34.07% | 1 | Dec 9, 2024 | |
| TBRG TruBridge | Maintains: Equal-Weight | $13 → $17 | $22.93 | -25.86% | 1 | Nov 20, 2024 | |
| SLP Simulations Plus | Initiates: Overweight | $39 | $29.92 | +30.35% | 1 | Nov 15, 2024 | |
| HCAT Health Catalyst | Maintains: Equal-Weight | $7 → $9 | $5.49 | +63.93% | 2 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $16 | $10.00 | +60.00% | 4 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $8 | $6.89 | +16.11% | 6 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $27.21 | +2.90% | 8 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $20 | $11.66 | +71.53% | 4 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $28 | $9.09 | +208.03% | 2 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $14.58 | +37.17% | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $3.9 | $3.57 | +9.24% | 2 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $3 | $4.24 | -29.25% | 3 | May 6, 2022 |
Privia Health Group
Jan 7, 2025
Reiterates: Overweight
Price Target: $26
Current: $22.24
Upside: +16.91%
Definitive Healthcare
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5
Current: $3.94
Upside: +26.90%
Doximity
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $55
Current: $53.72
Upside: +2.38%
Veeva Systems
Dec 20, 2024
Initiates: Overweight
Price Target: n/a
Current: $216.59
Upside: -
OptimizeRx
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5.5
Current: $4.81
Upside: +14.46%
IQVIA Holdings
Dec 20, 2024
Initiates: Overweight
Price Target: $250
Current: $197.36
Upside: +26.67%
Hallador Energy Company
Dec 9, 2024
Initiates: Buy
Price Target: $17
Current: $12.68
Upside: +34.07%
TruBridge
Nov 20, 2024
Maintains: Equal-Weight
Price Target: $13 → $17
Current: $22.93
Upside: -25.86%
Simulations Plus
Nov 15, 2024
Initiates: Overweight
Price Target: $39
Current: $29.92
Upside: +30.35%
Health Catalyst
Nov 14, 2024
Maintains: Equal-Weight
Price Target: $7 → $9
Current: $5.49
Upside: +63.93%
Nov 8, 2024
Downgrades: Equal-Weight
Price Target: $16
Current: $10.00
Upside: +60.00%
Oct 9, 2024
Maintains: Overweight
Price Target: $10 → $8
Current: $6.89
Upside: +16.11%
May 31, 2024
Reiterates: Overweight
Price Target: $28
Current: $27.21
Upside: +2.90%
Oct 11, 2023
Reiterates: Overweight
Price Target: $20
Current: $11.66
Upside: +71.53%
Jul 26, 2023
Reiterates: Equal-Weight
Price Target: $28
Current: $9.09
Upside: +208.03%
Aug 5, 2022
Maintains: Overweight
Price Target: $15 → $20
Current: $14.58
Upside: +37.17%
May 11, 2022
Maintains: Underweight
Price Target: $5 → $3.9
Current: $3.57
Upside: +9.24%
May 6, 2022
Maintains: Neutral
Price Target: $4 → $3
Current: $4.24
Upside: -29.25%